As shown in Fig. 2A, high expression of NT5E, RAP1GAP2, SDPR, SCEL, LPCAT2, SMURF2, and CTGF were significantly associated with the poor survival of BC patients among the candidate proteins (Fig. 2A). This evidence concerns the gene SMURF2 and breast cancer.